12 June 2024
12 June 2024
Experts highlighted the need to address a gap in UK regulatory timelines compared to international standards.
Artificial intelligence (AI) has the potential to revolutionize drug development through improved efficiency, accuracy, and speed.
Early diagnosis of chronic kidney disease has both economic and environmental benefits, according to AstraZeneca’s Mina Makar.
The funds will be used to advance PD1-IL18 immunoconjugate BPT567 into early-stage trials for solid tumours.
The company secured $15.5m in a seed funding round from investors in 2023.
Levitate Bio will operate as a wholly-owned Rosetta Commons Foundation subsidiary.
The investment is part of a larger €1.5bn initiative to expand the site's capabilities by 2025.
Tacalyx will use the funding to develop pipeline candidates and explore further partnership options to elevate its cancer research.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
